Clinical Trial Update: Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares golcadomide plus R-CHOP to placebo plus R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Golcadomide (golcadomide)
• Rituximab (rituximab)

Snippet

Sponsor: Celgene | Conditions: Large B-cell Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING